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Résumé en
anglais
Advanced glycation end-products (AGEs) are associated with many pathogenic
disorders such as pathogenesis of diabetes or endothelial dysfunction leading to
cardiovascular events. Therefore, the identification of new anti-AGE molecules or
extracts aims at preventing such pathologies. Many Clusiaceae and Calophyllaceae
species are used in traditional medicines to treat arterial hypertension as well as
diabetes. Focusing on these plant families, an anti-AGE plant screening allowed us to
select Mammea neurophylla for further phytochemical and biological studies. Indeed,
both DCM and MeOH stem bark extracts demonstrated in vitro their ability to prevent
inflammation in endothelial cells and to reduce vasoconstriction. A bioguided
fractionation of these extracts allowed us to point out 4-phenyl- and 4-(1-
acetoxypropyl)coumarins and procyanidins as potent inhibitors of AGE formation,
potentially preventing endothelial dysfunction. The fractionation steps also led to the
isolation of two new compounds, namely neurophyllols A and B from the DCM bark
extract together with thirteen known mammea A and E coumarins (mammea A/AA,
mammea A/AB, mammea A/BA, mammea A/BB, mammea A/AA cycloD, mammea A/AB
cycloD, disparinol B, mammea A/AB cycloE, ochrocarpin A, mammea A/AA cycloF,
mammea A/AB cycloF, mammea E/BA, mammea E/BB) as well as δ-tocotrienol,
xanthones (1-hydroxy-7-methoxyxanthone, 2-hydroxyxanthone) and triterpenes
(friedelin and betulinic acid). During this study, R,S-asperphenamate, previously


















































Publié sur Okina (http://okina.univ-angers.fr)
